# Safety and Efficacy of Adjunctive GM1 to Mechanical Thrombectomy for Acute Anterior Circulation Large Vessel Occlusion

> **NCT07519044** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Xuanwu Hospital, Beijing** · enrollment: 868 (estimated)

## Conditions studied

- Stroke
- Acute Ischemic Stroke

## Interventions

- **DRUG:** Intravenous GM1 Therapy
- **DRUG:** Placebo Therapy

## Key facts

- **NCT ID:** NCT07519044
- **Lead sponsor:** Xuanwu Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-30
- **Primary completion:** 2027-01-31
- **Final completion:** 2028-08-31
- **Target enrollment:** 868 (ESTIMATED)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07519044

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07519044, "Safety and Efficacy of Adjunctive GM1 to Mechanical Thrombectomy for Acute Anterior Circulation Large Vessel Occlusion". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07519044. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
